Zogenix, Inc. Reports Granting Of Inducement Award Under Nasdaq Listing Rule 5635(C)(4)
Published: Dec 23, 2013
SAN DIEGO, Dec. 20, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system disorders and pain, reported today that it has issued an inducement award to Bradley S. Galer, M.D., the company's newly appointed Executive Vice President and Chief Medical Officer.
Help employers find you! Check out all the jobs and post your resume.